Life Sciences AISeries AWorkflowℹNew York City startups
Series A: A Series — June 2026 In June 2026, 26 New York City startups announced Series A rounds — the second-largest cohort we’ve tracked since….
Startup snapshot
- Stage
- Series A
- Funding
- Series A · $1.4 b · Jul 2, 2026
- Status
- published
- Updated
- Nov 2, 2026
- Views
- Category
- Life Sciences AI
- Website
- new-york-city-startups.com
What they're building
Series A: A Series — June 2026 In June 2026, 26 New York City startups announced Series A rounds — the second-largest cohort we’ve tracked since….
Foundation model usage
Editorial estimates from product descriptions. Model providers and actual usage are not confirmed.
- Inferred architecture
- Multimodal processing, Embeddings & semantic search
- Potential advantages
- Workflow lock-in
- Estimated model demand
- High intensity
NYC footprint
- NYC location
- New York, NY
Funding
Latest funding: Series A · $1.4 b · Jul 2, 2026.
AI Lab Fit
Strong fit for multimodal biological data, literature synthesis, experiment planning, and structured scientific reasoning.
Notes
New York City startups is tagged workflow based on buyer clarity, repeat workflow activity, public activity, and fit with the AI Atlas map.
Related NYC startups
From Humanities To AI: How Ali Hussain Built Fintech Tabs Into A $400M Startup Our third in a series of articles about non-tech founders getting venture….
Life Sciences AIWorkflowℹRecent Activity
Output Biosciences is building Large Biological Models, generative AI architectures designed to handle the long, nonlinear, fragmented data of biological systems across molecules, cells, and organisms.
Life Sciences AIWorkflowℹ115viewsRecent Activity
Proxima Bio, formerly VantAI, is an AI-native platform for proximity-based drug discovery, mapping protein-protein interactions to design medicines that reshape protein networks rather than inhibit single targets.
Life Sciences AIWorkflowℹ160viewsRecent Activity